SA Shurtleff

921 total citations
9 papers, 706 citations indexed

About

SA Shurtleff is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, SA Shurtleff has authored 9 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Hematology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in SA Shurtleff's work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). SA Shurtleff is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). SA Shurtleff collaborates with scholars based in United States and Canada. SA Shurtleff's co-authors include C-H Pui, SC Raimondi, DR Head, F G Behm, J R Downing, Raul C. Ribeiro, JR Downing, FG Behm, David R. Head and Wayne L. Furman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

SA Shurtleff

9 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SA Shurtleff United States 9 377 311 292 150 144 9 706
S Raimondi United States 11 707 1.9× 437 1.4× 515 1.8× 143 1.0× 137 1.0× 19 1.1k
SB Murphy United States 12 498 1.3× 473 1.5× 175 0.6× 118 0.8× 120 0.8× 24 779
TE Hansen-Hagge Germany 11 346 0.9× 393 1.3× 226 0.8× 103 0.7× 213 1.5× 15 695
CR Bartram Germany 11 453 1.2× 309 1.0× 206 0.7× 78 0.5× 109 0.8× 17 668
Silja Röttgers Germany 13 463 1.2× 453 1.5× 199 0.7× 71 0.5× 192 1.3× 14 778
L Elia Italy 13 507 1.3× 461 1.5× 216 0.7× 62 0.4× 109 0.8× 29 691
OA Haas Austria 15 656 1.7× 369 1.2× 407 1.4× 68 0.5× 128 0.9× 18 904
SP Hunger United States 14 636 1.7× 491 1.6× 491 1.7× 67 0.4× 117 0.8× 21 986
Dieter K. Hossfeld Germany 14 746 2.0× 366 1.2× 304 1.0× 93 0.6× 137 1.0× 24 920
TR Golub United States 6 426 1.1× 458 1.5× 274 0.9× 53 0.4× 103 0.7× 7 708

Countries citing papers authored by SA Shurtleff

Since Specialization
Citations

This map shows the geographic impact of SA Shurtleff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SA Shurtleff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SA Shurtleff more than expected).

Fields of papers citing papers by SA Shurtleff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SA Shurtleff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SA Shurtleff. The network helps show where SA Shurtleff may publish in the future.

Co-authorship network of co-authors of SA Shurtleff

This figure shows the co-authorship network connecting the top 25 collaborators of SA Shurtleff. A scholar is included among the top collaborators of SA Shurtleff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SA Shurtleff. SA Shurtleff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Andersson, Anna, D. W. Miller, Julie A. Lynch, et al.. (2011). IDH1 and IDH2 mutations in pediatric acute leukemia. Leukemia. 25(10). 1570–1577. 72 indexed citations
3.
Kane, Javier R., David R. Head, Louisa Balázs, et al.. (1996). Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemia.. PubMed. 10(8). 1296–302. 23 indexed citations
4.
Rubnitz, Jeffrey E., FG Behm, AJ Carroll, et al.. (1996). Molecular analysis of t(11;19) breakpoints in childhood acute leukemias. Blood. 87(11). 4804–4808. 47 indexed citations
5.
Downing, JR, SA Shurtleff, Maria Zieleńska, et al.. (1995). Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood. 85(12). 3416–3422. 122 indexed citations
6.
Mathew, Prasad, S. W. Morris, Javier R. Kane, et al.. (1995). Localization of the murine homolog of the anaplastic lymphoma kinase (<i>ALK</i>) gene on mouse Chromosome 17. Cytogenetic and Genome Research. 70(1-2). 143–144. 8 indexed citations
7.
Shurtleff, SA, Samuel P. Meyers, SC Raimondi, et al.. (1995). Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. Blood. 85(12). 3695–3703. 77 indexed citations
8.
Okuda, Tsukasa, SA Shurtleff, SC Raimondi, et al.. (1995). Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood. 85(9). 2321–2330. 142 indexed citations
9.
Pui, C-H, F G Behm, J R Downing, et al.. (1994). 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.. Journal of Clinical Oncology. 12(5). 909–915. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026